Filament Health undertakes innovative clinical trial

Mugglehead
By Rowan DunneJul 11, 2022, 10:45 pm254 pts
A British Columbia-based psychedelic drug company has recently extended some innovational research down south into San Fransisco. On Thursday, Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) revealed that the company would begin administering doses of naturally derived psilocin in a new FDA-approved…

Read Article Share
Share Article
- email
- twitter
- facebook
- pocket
- reddit
- tumblr
- linkedin
- pinterest

Trending Today on NewsBudz

Jungle Boys Opening 1st Arizona Dispensary in Phoenix 40

About NewsBudz

NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.

Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.

Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.